Figure 1.

Immunohistochemical MDR-1 expression in RCCs. Representative examples of RCCs with low (A: ×100; B: ×250) and high (C: ×400; D: ×400) MDR-1 expression, as evaluated by immunohistochemistry (LSAB-HRP, nuclear counterstaining with haematoxylin).

Mignogna et al. BMC Cancer 2006 6:293   doi:10.1186/1471-2407-6-293
Download authors' original image